IT1257793B - Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato - Google Patents

Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato

Info

Publication number
IT1257793B
IT1257793B ITBO920183A ITBO920183A IT1257793B IT 1257793 B IT1257793 B IT 1257793B IT BO920183 A ITBO920183 A IT BO920183A IT BO920183 A ITBO920183 A IT BO920183A IT 1257793 B IT1257793 B IT 1257793B
Authority
IT
Italy
Prior art keywords
microgranules
pharmaceutical composition
controlled release
composition based
biliary acids
Prior art date
Application number
ITBO920183A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITBO920183A priority Critical patent/IT1257793B/it
Publication of ITBO920183A0 publication Critical patent/ITBO920183A0/it
Priority to EP93830203A priority patent/EP0571338A1/en
Priority to CA002096394A priority patent/CA2096394A1/en
Priority to JP5116215A priority patent/JPH0632739A/ja
Priority to US08/063,442 priority patent/US5422124A/en
Publication of ITBO920183A1 publication Critical patent/ITBO920183A1/it
Application granted granted Critical
Publication of IT1257793B publication Critical patent/IT1257793B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Una composizione farmaceutica per uso orale a rilascio controllato del principio attivo comprendente una molteplicità di microgranuli ognuno dei quali è costituito da un nucleo di acido biliare e legante e da una membrana, applicata su detto nucleo di principio attivo, in grado di cedere detto acido biliare in tempi successivi a scadenza sostanzialmente regolare.
ITBO920183A 1992-05-18 1992-05-18 Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato IT1257793B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITBO920183A IT1257793B (it) 1992-05-18 1992-05-18 Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato
EP93830203A EP0571338A1 (en) 1992-05-18 1993-05-14 Pharmaceutical oral controlled release composition comprising small pellets of bile acids
CA002096394A CA2096394A1 (en) 1992-05-18 1993-05-17 Pharmaceutical oral controlled release composition comprising small pellets of bile acids
JP5116215A JPH0632739A (ja) 1992-05-18 1993-05-18 胆汁酸の小ペレットを含有する徐放性経口薬剤組成物
US08/063,442 US5422124A (en) 1992-05-18 1993-05-18 Pharmaceutical oral controlled release composition comprising small pellets of bile acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO920183A IT1257793B (it) 1992-05-18 1992-05-18 Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato

Publications (3)

Publication Number Publication Date
ITBO920183A0 ITBO920183A0 (it) 1992-05-18
ITBO920183A1 ITBO920183A1 (it) 1993-11-18
IT1257793B true IT1257793B (it) 1996-02-13

Family

ID=11338261

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO920183A IT1257793B (it) 1992-05-18 1992-05-18 Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato

Country Status (5)

Country Link
US (1) US5422124A (it)
EP (1) EP0571338A1 (it)
JP (1) JPH0632739A (it)
CA (1) CA2096394A1 (it)
IT (1) IT1257793B (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
ITMI20012572A1 (it) * 2001-12-06 2003-06-06 Istituto Biochimico Italiano Microgranuli di acido ursodesossicolico
JP2010524926A (ja) * 2007-04-19 2010-07-22 ディスパル・インターナショナル・ビー．ブイ． ウルソデオキシコール酸の高用量組成物
KR101228632B1 (ko) 2008-03-06 2013-01-31 레버리지 디자인 엘티디. 피벗 차축을 구비한 이송 장치
US20110268794A1 (en) * 2009-01-09 2011-11-03 Camilleri Michael L Methods and materials for delivering bile acids
ES2586931T3 (es) 2010-11-04 2016-10-19 Albireo Ab Inhibidores de IBAT para el tratamiento de enfermedades hepáticas
RU2619215C2 (ru) * 2010-11-08 2017-05-12 Альбирео Аб Фармацевтическая комбинация, включающая ibat-ингибитор и связующее желчной кислоты
JO3301B1 (ar) 2013-04-26 2018-09-16 Albireo Ab تعديلات بلورية على إيلوبيكسيبات
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
EP3413875B1 (en) 2016-02-09 2020-01-29 Albireo AB Cholestyramine pellets and methods for preparation thereof
EP3413878B1 (en) 2016-02-09 2021-04-14 Albireo AB Oral cholestyramine formulation and use thereof
EP3413877B1 (en) 2016-02-09 2021-04-07 Albireo AB Oral cholestyramine formulation and use thereof
JP2020530448A (ja) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
JP7391048B2 (ja) 2018-06-05 2023-12-04 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
MX2020013839A (es) 2018-06-20 2021-03-25 Albireo Ab Formulacion farmaceutica de odevixibat.
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3859437A (en) * 1972-06-02 1975-01-07 Intellectual Property Dev Corp Reducing cholesterol levels
FR2152379A1 (en) * 1971-09-09 1973-04-27 Henry Michel Bile acid/dried pancreas compositions - for treating obesity
IT1076001B (it) * 1977-01-04 1985-04-22 Also Lab Di Dr P Sorbini & C S Composizione per il trattamento del cuoio capelluto e contro la caduta dei capelli
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
IT1142639B (it) * 1981-12-29 1986-10-08 Proter Spa Composizioni terapeutiche ad attivita' coleretica contenenti come principio attivo derivati dall'acido colanico
IT1213390B (it) * 1986-11-28 1989-12-20 Gipharmex Spa Composizioni farmaceutiche ad uso orale del tipo a cessione controllata nel tempo contenenti composti a struttura steroidea attivi nelle alterazioni del metabolismo del colesterolo.
IT1212141B (it) * 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
US5091192A (en) * 1990-01-16 1992-02-25 Natur-All Systems, Inc. Bile salts permanently bound to insoluble cellulose as a dietary supplement

Also Published As

Publication number Publication date
ITBO920183A0 (it) 1992-05-18
CA2096394A1 (en) 1993-11-19
JPH0632739A (ja) 1994-02-08
EP0571338A1 (en) 1993-11-24
ITBO920183A1 (it) 1993-11-18
US5422124A (en) 1995-06-06

Similar Documents

Publication Publication Date Title
AR065072A2 (es) Una formulacion medicamentosa de pellet de difusion controlada que tiene liberacion controlada de un compuesto activo
ES2103563T3 (es) Esteres nitricos con una actividad farmacologica y procedimiento para su preparacion.
AT400295B (de) Orale feste pharmazeutische dosierungsform mit programmierter wirkstofffreisetzung und verfahren zu ihrer herstellung
DE60118395D1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen
DE69002604D1 (de) Pharmazeutische zubereitung mit verzoegerter freisetzung und seine herstellung.
ATE324872T1 (de) Orale pharmazeutische zusammensetzung mit verzögerter wirkstofffreigabe von protonenpumpen- hemmern
CL2004001182A1 (es) Composicion farmaceutica que comprende a una microparticula de liberacion sostenida la que contiene a un derivado de 1,2 benzazol; procedimiento de preparacion de la microparticula; util como broncodilatador, antipsicoticos y en otros problemas del s
DE3482374D1 (de) Pharmazeutische zusammensetzung mit verzoegerter abgabe.
ITMI942484A0 (it) Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
AR024492A1 (es) Formas de dosificacion farmaceutica para liberacion controlada que comprenden al menos un impulso ciclico
FI971986A7 (fi) Farmaseuttisia nanosuspensioita lääkeaineen antamiseen systeemeinä, joissa on kasvanut kyllästysliukoisuus ja liukenemisnopeus
ATE68969T1 (de) Im magen verbleibende granula.
ES2001897A6 (es) Procedimiento para la fabricacion de una tableta de liberacion controlada
NO970361D0 (no) Spraybart filmdannende system som frigjör aktive stoffer for anvendelse på planter
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
DE60232147D1 (de) Pharmazeutische zubereitung mit verzögerter wirkstoff-freisetzung enthaltend milchsäure-glycolsäure copolymer, und verfahren zu deren herstellung
ITBO910114A1 (it) Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
HUT63374A (en) Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compositions comprising such active ingredient
DK1169032T3 (da) Ketoprofen-mikrogranuler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
NO174032C (no) Fremgangsmåte for fremstilling av en legemiddel-polymer-matriks innbefattende dimenhydrinat som en aktiv bestanddel
ES2165232T3 (es) Sistema terapeutico transdermico (tts) que contiene oxibutinina.
FI945510A0 (fi) Klavulaanihapon diamiinisuolat
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970529